Cargando…
Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data
BACKGROUND: Treatment with onabotulinumtoxin A (BT-A) is safe and effective for chronic migraine (CM). Several studies assessed possible predictors of response to treatment with BT-A, but there is little knowledge on the frequency and predictors of sustained response. The aim of this study was to ev...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Milan
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183653/ https://www.ncbi.nlm.nih.gov/pubmed/32334534 http://dx.doi.org/10.1186/s10194-020-01113-6 |